Family Legacy Inc. acquired a new stake in Corteva (NASDAQ:CTVA) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 9,217 shares of the company’s stock, valued at approximately $273,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Manchester Financial Inc. acquired a new stake in Corteva during the second quarter worth approximately $30,000. Central Bank & Trust Co. bought a new position in Corteva in the second quarter valued at approximately $31,000. Atwood & Palmer Inc. bought a new position in Corteva in the second quarter valued at approximately $33,000. Truewealth LLC bought a new position in Corteva in the second quarter valued at approximately $36,000. Finally, Baldwin Brothers Inc. MA bought a new stake in shares of Corteva during the second quarter worth $37,000.
In related news, Director Gregory R. Page bought 2,000 shares of Corteva stock in a transaction dated Monday, June 3rd. The stock was purchased at an average cost of $25.49 per share, with a total value of $50,980.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
A number of analysts have weighed in on the stock. Monness Crespi & Hardt assumed coverage on shares of Corteva in a research note on Wednesday, July 17th. They set a “sell” rating and a $24.00 target price on the stock. Jefferies Financial Group assumed coverage on shares of Corteva in a research note on Wednesday, May 29th. They set a “buy” rating on the stock. Sanford C. Bernstein assumed coverage on shares of Corteva in a research note on Wednesday, June 5th. They issued a “market perform” rating and a $31.00 price objective on the stock. SunTrust Banks assumed coverage on shares of Corteva in a research note on Monday, June 3rd. They issued a “hold” rating and a $29.00 price objective on the stock. Finally, JPMorgan Chase & Co. assumed coverage on shares of Corteva in a research note on Friday, June 21st. They issued an “overweight” rating and a $30.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $31.21.
NASDAQ:CTVA opened at $31.46 on Monday. The stock’s 50-day simple moving average is $27.99. Corteva has a one year low of $24.35 and a one year high of $32.78.
Corteva (NASDAQ:CTVA) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.43. The firm had revenue of $5.56 billion during the quarter, compared to the consensus estimate of $5.47 billion. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Wednesday, July 31st will be given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend is Tuesday, July 30th.
Featured Story: Equity Income
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva (NASDAQ:CTVA).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.